Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.

Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, Davidkin I, Ziegler T, Julkunen I.

Euro Surveill. 2010 Feb 4;15(5). pii: 19478.

2.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M.

Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7.

PMID:
20096450
3.

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L.

Emerg Infect Dis. 2009 Dec;15(12):2004-7. doi: 10.3201/eid1512.091413.

4.

Australia's winter with the 2009 pandemic influenza A (H1N1) virus.

Bishop JF, Murnane MP, Owen R.

N Engl J Med. 2009 Dec 31;361(27):2591-4. doi: 10.1056/NEJMp0910445. No abstract available.

6.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453.

7.

The transmissibility and control of pandemic influenza A (H1N1) virus.

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.

Science. 2009 Oct 30;326(5953):729-33. doi: 10.1126/science.1177373.

8.

Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

National Center for Immunization and Respiratory Diseases, CDC.; Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8.

9.

Original antigenic sin responses to influenza viruses.

Kim JH, Skountzou I, Compans R, Jacob J.

J Immunol. 2009 Sep 1;183(5):3294-301. doi: 10.4049/jimmunol.0900398.

10.

Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4.

11.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225.

12.

Pandemic potential of a strain of influenza A (H1N1): early findings.

Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C; WHO Rapid Pandemic Assessment Collaboration..

Science. 2009 Jun 19;324(5934):1557-61. doi: 10.1126/science.1176062.

13.

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L.

N Engl J Med. 2009 Jun 18;360(25):2616-25. doi: 10.1056/NEJMoa0903812. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

14.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team., Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM.

N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

15.

Phylogeny.fr: robust phylogenetic analysis for the non-specialist.

Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O.

Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W465-9. doi: 10.1093/nar/gkn180.

16.

Social contacts and mixing patterns relevant to the spread of infectious diseases.

Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ.

PLoS Med. 2008 Mar 25;5(3):e74. doi: 10.1371/journal.pmed.0050074.

17.

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM.

PLoS One. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501.

18.

The influenza virus resource at the National Center for Biotechnology Information.

Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D.

J Virol. 2008 Jan;82(2):596-601. No abstract available.

19.

Influenza vaccine: the challenge of antigenic drift.

Carrat F, Flahault A.

Vaccine. 2007 Sep 28;25(39-40):6852-62. Review.

PMID:
17719149
20.

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54.

Items per page

Supplemental Content

Support Center